Oasis Labs

Oasis Labs is a research compound supplier with over 54 active listings on Peptides.SO, offering a catalog that spans GLP-1 receptor agonist research compounds, BPC-157, metabolic research agents, cognitive peptides, growth hormone-axis compounds, NAD+ formulations, and antioxidant research compounds. The company's catalog architecture reflects the modern demand profile in the research peptide market, with strong representation in the high-interest GLP receptor biology and tissue repair segments.

The GLP-1 research compound lineup is a central catalog pillar. GLP-3 (Retatrutide) is available in multiple dose formats — Retatrutide is a triple agonist of GLP-1R, GIPR, and GCGR receptors, studied in advanced metabolic biology research for its multi-receptor engagement profile and effects on adipose tissue lipolysis, hepatic lipid metabolism, and energy expenditure. Retatrutide's triple-receptor activity distinguishes it from dual-agonist compounds such as Tirzepatide, and it represents a frontier compound for researchers studying the convergent biology of GLP-1, GIP, and glucagon signaling pathways. Oasis Labs also lists Reta 10mg (compact format for smaller research programs) and CagriSema formulations.

BPC-157 (Body Protection Compound-157) is among the most-researched gastrointestinal and tissue repair peptides in the catalog. BPC-157 has been studied in mucosal healing models, angiogenesis, tendon and ligament repair, and systemic anti-inflammatory contexts. Oasis Labs carries multiple BPC-157 formats, supporting varied experimental dosing and concentration requirements.

Metabolic research coverage includes Tesofensine, a norepinephrine/dopamine/serotonin reuptake inhibitor studied in appetite regulation and weight management research, and MOTS-c, a mitochondria-derived peptide studied in insulin sensitivity, exercise adaptation, and metabolic homeostasis contexts. SLU-PP-332 Tablets are available for researchers studying estrogen-related receptor (ERR) agonist pharmacology and exercise-mimetic metabolic biology.

Cognitive research agents include Selank (a synthetic analog of tuftsin with anxiolytic and immunomodulatory properties in research models) and Semax (an ACTH4-7 proline-glycine-proline fragment studied in neuroprotection, cerebral blood flow, and cognitive enhancement research). These nootropic peptides appeal to researchers in neuropharmacology and central nervous system biology.

The anti-aging and NAD+ segment includes Epitalon (a tetrapeptide from the Khavinson bioregulator program studied in telomere biology and pineal gland research), Glutathione (a tripeptide antioxidant central to cellular redox homeostasis), and NAD+ in multi-vial formats. All Oasis Labs products are sold strictly for in-vitro laboratory research and are not intended for human or veterinary administration.